SSB Form 144 Filing: Insider Sale of 5,000 Common Shares via Morgan Stanley
Rhea-AI Filing Summary
Form 144 notice for SouthState Corporation (SSB) reports a proposed sale of 5,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $497,982 and 101,208,988 shares outstanding. The filing lists prior acquisitions of the securities from the issuer as performance shares and restricted stock between 01/01/2022 and 12/31/2024, totaling the reported lots. No securities were sold in the past three months per the filing. The filer certifies no undisclosed material adverse information and provides the required representations for Rule 144 compliance.
Positive
- Public disclosure of proposed sale through an established broker (Morgan Stanley Smith Barney LLC) enhances transparency
- Acquisitions are documented as performance shares and restricted stock, supporting compliance with Rule 144 provenance requirements
- No sales in past three months reported, which may indicate the seller has not been actively disposing of holdings recently
Negative
- Insider sale reported, which some investors may view negatively despite being small relative to shares outstanding
Insights
TL;DR: Small proposed insider sale equal to roughly 0.0049% of the outstanding shares; appears routine and compliance-focused.
The filing shows a single proposed sale of 5,000 common shares with an aggregate market value of $497,982, to be executed via Morgan Stanley Smith Barney on 08/22/2025. The securities were acquired in the form of performance shares and restricted stock from the issuer across 2022–2024. The notice includes the required certification that no material non-public information is known to the seller. Given the size relative to shares outstanding, the transaction appears immaterial to market capitalization but is material disclosure for insider trading transparency.
TL;DR: Form 144 is a standard Rule 144 disclosure; documentation of award origins supports compliance; no recent sales reported.
The submission documents the provenance of the shares (performance shares and restricted stock) and dates of acquisition, which aligns with Rule 144 requirements to show holding origin and payment terms. The form states there were no sales in the prior three months and contains the standard representation regarding material adverse information and 10b5-1 plan language. From a governance perspective, the filing meets routine disclosure expectations and preserves market transparency.